VEGF Inhibitor PTC299

An orally bioavailable, small molecule inhibitor of vascular endothelial growth factor (VEGF) synthesis with potential antiangiogenesis and antineoplastic activities. VEGF inhibitor PTC299 targets post-transcriptionally by selectively binding the 5'- and 3'-untranslated regions (UTR) of VEGF messenger RNA (mRNA), thereby preventing translation of VEGF. This inhibits VEGF protein production and decreases its levels in the tumor and bloodstream. In turn, this may result in the inhibition of migration, proliferation and survival of endothelial cells, microvessel formation, the inhibition of tumor cell proliferation, and eventually the induction of tumor cell death. VEGFs are upregulated in a variety of tumor cell types and play key roles during angiogenesis. In addition, PTC299 may enhance the antitumor activity of other chemotherapeutic agents. (NCI Thesaurus)

YOU MAY ALSO LIKE

VEGF

A substance made by cells that stimulates new blood vessel formation. Also called vascular endothelial growth factor.

Vegetarian Diet

A vegetarian diet focuses on plants for food. These include fruits, vegetables, dried beans and peas, grains, seeds and nuts. There is…

Vegetarian

A person who eats no meat; some may eat fish, eggs, or dairy products.

Vegan Diet

A type of vegetarian diet that excludes all animal products, including dairy, eggs, meat, poultry, fish, and animal fats.

Vegan

A person who does not eat any foods that come from animals, including meat, eggs, and dairy products. A vegan diet is…

Vecuronium Bromide

The bromide salt form of vecuronium, a synthetic steroid derivative of the naturally occurring alkaloids of curare with a muscle relaxant…